Personalized Vaccine for Patients With Recurrent Malignant Glioma

Clinical trial NCT04943718 · UNKNOWN

Trial details

NCT number: NCT04943718
Sponsor: Xuanwu Hospital, Beijing
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Glioma Recurrent Glioma

Start date: 2021-07-15
Primary completion: 2023-06-13
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.